1 / 8

Parasympatholytic

Introduction of Parasympatholytics : M blockers: Atropine, Cyclopentolate , Scopolamine, Tropicamide N1 Blockers: Nicotine N2 Blockers: Tubocurarine , Atracurium. Parasympatholytic. Atropine Pharmaceutical chemistry Possible Origin Physiochemical Properties Idea of Retro-synthesis

mfullerton
Download Presentation

Parasympatholytic

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction of Parasympatholytics:M blockers: Atropine, Cyclopentolate, Scopolamine, TropicamideN1 Blockers: Nicotine N2 Blockers:Tubocurarine, Atracurium

  2. Parasympatholytic • Atropine • Pharmaceutical chemistry • Possible Origin • Physiochemical Properties • Idea of Retro-synthesis • Molecular pharmacology • Mechanism of action: Anti-muscarinic • Structure-based explanation of Therapeutic uses: Mydriatic for measuring refractive errors of the eyes, (week-2 week duration). Replaced by short acting anti-cholinergics, Antispasmodic, anti-dote for mushroom poisoning and antisecretory. • Structure-based explanation of Side effects: dry mouth, blurred vision, Sandy eyes, tachycardia, constipation, restless and confusion. • Analysis

  3. Parasympatholytic • Cyclopentolate (Cyclogyl) • Pharmaceutical chemistry • Possible Origin • Physiochemical Properties • Idea of Retro-synthesis • Molecular pharmacology • Mechanism of action: • Structure-based explanation of Therapeutic uses: short acting for mydriasis (24 hours) • Structure-based explanation of Side effects: • Analysis

  4. Parasympatholytic • Scopolamine • Pharmaceutical chemistry • Possible Origin • Physiochemical Properties • Idea of Retro-synthesis • Molecular pharmacology • Mechanism of action: • Structure-based explanation of Therapeutic uses: motion sickness, block short-term memory and anti-spasmodic • Structure-based explanation of Side effects: • Analysis

  5. Parasympatholytic • Tropicamide (Mydriacyl) • Pharmaceutical chemistry • Possible Origin • Physiochemical Properties • Idea of Retro-synthesis • Molecular pharmacology • Mechanism of action: • Structure-based explanation of Therapeutic uses: short acting for mydriasis (6 hours) • Structure-based explanation of Side effects: • Analysis

  6. Parasympatholytic • Nicotine (Nicotinell) • Pharmaceutical chemistry • Possible Origin • Physiochemical Properties • Idea of Retro-synthesis • Molecular pharmacology • Mechanism of action: Ganglionic blocker (N2) • Structure-based explanation of Therapeutic uses: none • Structure-based explanation of Side effects: stimulation then paralysis of Ganglionic receptor, high blood pressure, increasing cardiac output, hypotension with high doses and low GI activity. • Analysis

  7. Parasympatholytic • Tubocurarine • Pharmaceutical chemistry • Possible Origin • Physiochemical Properties • Idea of Retro-synthesis • Molecular pharmacology • Mechanism of action: Neuromuscular blocker (N1) • Structure-based explanation of Therapeutic uses: Adjuvant drug in anaesthesia to facilitate intubation. • Structure-based explanation of Side effects: it sometimes increases histamine release and causes hypotension (allergy). Thus it is rarely used. • Analysis

  8. Parasympatholytic • Atracurium (Tracrium) • Pharmaceutical chemistry • Possible Origin • Physiochemical Properties • Idea of Retro-synthesis • Molecular pharmacology • Mechanism of action: • Structure-based explanation of Therapeutic uses: • Structure-based explanation of Side effects: well-tolerated • Analysis

More Related